Clinical trial
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
NCT06401707 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- May 20, 2024
- Completion date
- October 20, 2027
- Enrollment
- 52 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.